Thermo Fisher Scientific To Implement Darwin LIMS at APP Pharmaceuticals Inc.
Thermo Fisher Scientific Inc. has been selected by APP Pharmaceuticals Inc. (formerly known as Abraxis Pharmaceutical Products) for a three site multi-phase rollout of Thermo Scientific Darwin LIMS. Darwin, a purpose-built laboratory information management system (LIMS) for pharmaceutical manufacturing R&D and QA/QC, will be deployed in all three of APP's manufacturing facilities located in New York, Illinois and Puerto Rico.
APP Pharmaceuticals' products have helped millions of people in the United States and Canada fight critical illnesses by providing a broad portfolio of multi-source and branded injectable pharmaceutical products, including difficult to manufacture and urgently needed medical products. The project is intended to harmonize processes, automate operations and consolidate data management in a single LIMS across all three sites.
The multi-phase project will initially involve the deployment of Darwin's inherent Environmental Monitoring functionality enabling facilities to move from manual systems onto an automated system for microbiological samples from the sterile manufacturing environment.
The second phase of the project will feature an integrated LIMS and Chromatography Data System (CDS) implementation followed by the third phase of the LIMS rollout including SAP interfaces across all sites.
Thermo Scientific Darwin LIMS is a purpose-built LIMS for pharmaceutical manufacturing R&D and QA/QC laboratories. Since it contains an Environmental Monitoring module as standard, implementation and validation time and costs are greatly reduced versus generic LIMS. Environmental monitoring is essential for product monitoring and compliance. Thermo Scientific Atlas CDS is a GLP and 21 CFR Part 11 compliant enterprise CDS. Atlas CDS provides comprehensive multiple vendor instrument control. With ease of deployment and validation across laboratories and sites, laboratory efficiency is gained by automating the laboratory.
NOTE: This item is from our 'historic' database and may contain information which is not up to date.